07/20/2026
Check out new research in Annals of Internal Medicine led by Dr. Chintan Dave.
A new study analyzing U.S. insurance claims data found that people with who started GLP-1 receptor agonists had a modestly higher rate of ischemic optic neuropathy (ION), a condition causing sudden vision loss, compared with those taking SGLT2 or DPP-4 inhibitors. However, the absolute risk was very low, suggesting the findings may be influenced by differences in patient health characteristics rather than the medications themselves. https://bit.ly/4ymYCMj